XML 39 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 4,858 $ 36,423
Restricted cash 43,339 0
Short-term investments 51,092 72,240
Receivables    
Trade, less allowance for credit losses of $184 as of both December 31, 2022 and 2021 959 1,341
Related parties, less allowance for credit losses of $0 and $1,509 as of December 31, 2022 and 2021 19 73
Other 12,826 566
Inventory 287 326
Prepaid expenses and other 4,779 5,471
Current assets held for sale 0 40,188
Total current assets 118,159 156,628
Long-term investments 0 48,562
Property, plant and equipment, net 7,329 8,599
Intangible assets, net 44,455 52,291
Goodwill 36,923 37,554
Right-of-use assets 8,086 9,990
Other assets 1,025 936
Noncurrent assets held for sale 0 45,296
Total assets 215,977 359,856
Current liabilities    
Accounts payable 4,068 3,112
Accrued compensation and benefits 6,377 7,856
Other accrued liabilities 23,747 7,817
Deferred revenue 25 1,490
Current portion of long-term debt 43,219 52
Current portion of lease liabilities 1,209 1,393
Related party payables 0 74
Current liabilities held for sale 0 12,851
Total current liabilities 78,645 34,645
Long-term debt, net of current portion 0 179,882
Long-term portion of deferred revenue 1,818 23,023
Lease liabilities, net of current portion 6,992 8,747
Deferred tax liabilities 2,263 2,539
Long-term liabilities held for sale 0 3,672
Total liabilities 89,718 252,508
Commitments and Contingencies
Shareholders' equity    
Common stock, no par value, 400,000,000 shares authorized as of December 31, 2022 and 2021; and 208,150,021 shares and 206,739,874 shares issued and outstanding as of December 31, 2022 and 2021, respectively 0 0
Additional paid-in capital 1,998,314 2,022,701
Accumulated deficit (1,868,567) (1,915,556)
Accumulated other comprehensive (loss) income (3,488) 203
Total shareholders' equity 126,259 107,348
Total liabilities and shareholders' equity $ 215,977 $ 359,856